Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91ÌÒÉ« Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background: Sepsis remains a major cause of mortality in intensive care. Previous studies have pointed out that sepsis is caused by
excessive inflammatory responses, leading to cell and organ damage in a host. In addition, Toona sinensis is believed to possess antioxidant
and anti-inflammatory properties.
Objectives: To evaluate the effects of Toona sinensis leaf extracts (TS) on the cytokine levels in the RAW264.7 cells treated with LPS.
Methods: RAW264.7 macrophages were treated with TS extracts (25, 50, 75 �¼g/mL) for 2 hours before the treatment of LPS (1 �¼g/
ml) for 24 hours. Cytokines in the supernatants of cells were determined by Bio-Plex Pro mouse cytokine assay kit for IL-6, IL-10, and
TNF-�±, which IL-6 and TNF-�± were proinflammatory and IL-10 was anti-inflammatory cytokines.
Results: Compared with those in the control group, the levels of IL-6, TNF-�±, and IL-10 were increased in the LPS group without
TS. However, the levels of IL-6 and TNF-�± were significantly decreased in the LPS group with TS compared with those without TS.
Discussion: Our results indicated that the TS pretreatment could decrease the levels of IL-6 and TNF-�± in the RAW264.7 cells treated
with LPS. This finding was consistent with the report of Chao-Chuan Wang et al., who had proposed that the TS extracts could inhibit
the level of TNF-�± in microglia-mediated neuroinflammation by LPS. Additionally, HL Yang et al., demonstrated that the TS could
suppress LPS-induced inflammation and migration in vascular smooth muscle cells via NF-�ºB activation. Thus, we suggested that the
TS might decrease the levels of TNF-�± and IL-6 via inhibition of NF-�ºB pathway in RAW264.7 cells treated with LPS.
Conclusions: In summary, TS may be a potentially effective adjuvant therapy to LPS-induced sepsis.
Biography
Szu-Ying Wu has completed his Undergraduate studies at Chang Gung University and earned his Medical degree in 2012. He is a CAM resident at Kaohsiung Chang Gung Memorial Hospital with a major in Acupuncture and Traumatology. He is the Vice Secretary-general of Taiwan Association of Chinese Medicine and Pharmacy Quality. His research topics focus on low level laser acupuncture and treatment of sleep disorders. His recent clinical interest is Sports Medicine.